Q4 2021 13F Holders as of 12/31/2021
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
157M
-
Number of holders
-
181
-
Total 13F shares, excl. options
-
99.7M
-
Shares change
-
+2.86M
-
Total reported value, excl. options
-
$1.89B
-
Value change
-
+$31.2M
-
Put/Call ratio
-
0.81
-
Number of buys
-
83
-
Number of sells
-
-109
-
Price
-
$19.00
Significant Holders of TG THERAPEUTICS, INC. - Common Stock (TGTX) as of Q4 2021
265 filings reported holding TGTX - TG THERAPEUTICS, INC. - Common Stock as of Q4 2021.
TG THERAPEUTICS, INC. - Common Stock (TGTX) has 181 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 99.7M shares
of 157M outstanding shares and own 63.37% of the company stock.
Largest 10 shareholders include FMR LLC (20.7M shares), VANGUARD GROUP INC (12.1M shares), BlackRock Inc. (8.9M shares), MAVERICK CAPITAL LTD (6.03M shares), STATE STREET CORP (5.82M shares), WELLINGTON MANAGEMENT GROUP LLP (4.25M shares), Capital World Investors (4.17M shares), PICTET ASSET MANAGEMENT SA (2.39M shares), GEODE CAPITAL MANAGEMENT, LLC (2.31M shares), and RA CAPITAL MANAGEMENT, L.P. (2.21M shares).
This table shows the top 181 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.